Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-Induced Gastropathy
This study is currently recruiting participants.
Study NCT00641004.   Last updated on May 19, 2008.
Information provided by Otsuka Pharmaceutical, Inc., Philippines
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
NSAID Induced Gastropathy
Additional conditions recognized in this trial
Stomach Diseases
More general conditions related to this trial
Digestive System Diseases
Gastrointestinal Diseases
Interventions listed in this trial
Rebamipide and Esomeprazole
Additional drug interventions recognized in this trial
Omeprazole
Rebamipide
More general drug interventions related to this trial
Anti-Ulcer Agents
Antioxidants
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Otsuka Pharmaceutical, Inc., Philippines


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services